XML 68 R46.htm IDEA: XBRL DOCUMENT v3.21.2
STOCK BASED COMPENSATION (Tables)
6 Months Ended 12 Months Ended
Jun. 30, 2021
Dec. 31, 2020
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Schedule of stock-based compensation expense

Total stock-based compensation expense related to all of the Company’s stock-based awards granted is reported in the condensed consolidated statements of operations as follows (in thousands):

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Three Months Ended June 30, 

​

Six Months Ended June 30, 

​

​

2021

    

2020

    

2021

    

2020

Research and development

​

$

1,838

​

$

569

​

$

2,755

​

$

1,283

General and administrative expense

​

 

1,355

​

 

217

​

 

2,194

​

 

454

Sales and marketing expense

​

 

577

​

 

213

​

 

921

​

 

421

Cost of sales

​

 

229

​

 

75

​

 

346

​

 

175

Total stock-based compensation expenses

​

$

3,999

​

$

1,074

​

$

6,216

​

$

2,333

Total stock-based compensation expense related to all of the Company’s stock-based awards granted is reported in the consolidated statements of operations as follows (in thousands):

​

​

​

​

​

​

​

​

​

​

Years Ended December 31, 

​

    

2020

    

2019

Research and development

​

$

3,276

​

$

2,713

General and administrative expense

​

 

3,464

​

 

941

Sales and marketing expense

​

 

894

​

 

1,373

Cost of sales

​

 

372

​

 

188

Total stock-based compensation expenses

​

$

8,006

​

$

5,215

Schedule of option activity

There were 21,810,237 shares available for award under the 2020 Plan at June 30, 2021. The option activity of the Plans for the six months ended June 30, 2021, is as follows (shares in thousands):

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

    

​

    

Weighted-Average 

 

​

​

​

​

​

​

Weighted-Average 

​

Remaining 

 

Aggregate

​

​

Number of 

​

Exercise Price 

​

Contractual Term 

 

Intrinsic Value

​

    

Shares

    

per Share

    

(in years)

    

(in thousands)

Outstanding at January 1, 2021

​

19,553

​

$

1.53

​

7.75

​

$

306,408

Granted

 

—

​

$

—

 

​

​

​

​

Exercised

 

(2,846)

​

$

1.29

 

​

​

​

​

Forfeited/expired

 

(313)

​

$

1.43

 

​

​

​

​

Outstanding at June 30, 2021

 

16,394

​

$

1.57

 

7.40

​

$

162,737

Options vested at June 30, 2021

 

9,451

​

$

1.62

 

6.27

​

$

93,385

Options vested or expected to vest at June 30, 2021

 

15,807

​

$

1.58

 

7.34

​

$

156,825

There were 14,379,052 shares available for award under the 2020 Plan at December 31, 2020. The option activity of the 2015 Plan and Make Plan for the year ended December 31, 2020, is as follows (shares in thousands):

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

    

​

    

Weighted-Average 

 

​

​

​

​

​

​

Weighted-Average 

​

Remaining 

 

Aggregate

​

​

Number of 

​

Exercise Price 

​

Contractual Term 

 

Intrinsic Value

​

    

Shares

    

per Share

    

(in years)

    

(in thousands)

Outstanding at January 1, 2020

​

18,072

​

$

2.01

​

7.84

​

$

24,045

Granted

 

8,463

​

$

1.51

 

​

​

​

​

Exercised

 

(522)

​

$

0.62

 

​

​

​

​

Forfeited/expired

 

(6,460)

​

$

2.92

 

​

​

​

​

Outstanding at December 31, 2020

 

19,553

​

$

1.53

 

7.75

​

$

306,408

Options vested at December 31, 2020

 

10,905

​

$

1.53

 

6.52

​

$

170,868

Options vested or expected to vest at December 31, 2020

 

18,818

​

$

1.53

 

7.69

​

$

294,824

Schedule of RSU activity

RSU activity under the 2020 Plan for the six months ended June 30, 2021 is as follows (shares in thousands):

​

​

​

​

​

​

​

​

Shares Subject 

    

Weighted-Average

​

    

to Vesting

    

Grant Date Fair Value

Balance of unvested shares as of January 1, 2021

​

683

​

$ 8.02

Granted

​

4,461

​

$ 15.38

Vested

​

(44)

​

$ 8.13

Cancelled/Forfeited

​

(5)

​

$ 7.98

Balance of unvested shares as of June 30, 2021

​

5,095

​

$ 14.52

RSU activity under the 2020 Plan for the year ended December 31, 2020 is as follows (shares in thousands):

​

​

​

​

​

​

​

​

Shares subject 

    

Weighted Average

​

    

to Vesting

    

Grant Date Fair Value

Balance of unvested shares as of January 1, 2020

​

—

​

​

—

Granted

​

683

​

$

8.02

Vested

​

—

​

​

—

Balance of unvested shares as of December 31, 2020

​

683

​

$

8.02

Consultant    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Schedule of assumptions using Black-Scholes option-pricing model

​

​

​

​

​

​

​

​

Six Months Ended

​

​

​

June 30, 2020

​

Risk‑free interest rate

​

​

0.8

%

Expected volatility

​

​

54.3

%

Expected life (in years)

​

​

10.0

​

Expected dividend yield

​

​

—

​

Fair value of Common Stock

​

$

3.34

​

​

​

​

​

​

​

​

​

​

​

​

Years Ended December 31, 

​

​

    

2020

    

2019

​

Risk‑free interest rate

​

​

0.6% – 0.8

%

​

1.4% – 3.1

%

Expected volatility

​

 

54.3% – 54.8

%

 

52.4% – 61.5

%

Expected life (in years)

​

 

9.4 – 10.0

​

 

6.2 – 10.0

​

Expected dividend yield

​

 

—

​

 

—

​

Fair value of Common Stock

​

$

1.40 – 7.98

​

$

3.34

​

Employee    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Schedule of assumptions using Black-Scholes option-pricing model

​

​

​

​

​

​

​

​

​

​

​

Three Months Ended

 

Six Months Ended

 

​

​

June 30, 2020

 

June 30, 2020

 

Risk‑free interest rate

​

​

0.4 % – 0.9

%

​

0.4 % – 0.9

%

Expected volatility

​

​

52.7 % – 54.2

%

​

52.7 % – 54.2

%

Expected life (in years)

​

​

5.9 – 6.3

​

​

5.9 – 6.3

​

Expected dividend yield

​

​

—

​

​

—

​

Fair value of Common Stock

​

$

3.34

​

$

3.34

​

​

​

​

​

​

​

​

​

​

​

​

Years Ended December 31, 

 

​

    

2020

    

2019

 

Risk‑free interest rate

​

​

0.3% – 1.7

%

​

1.7% – 2.6

%

Expected volatility

​

 

52.7% – 54.2

%

​

52.7% – 53.6

%

Expected life (in years)

​

 

5.9 – 6.3

 

​

5.6 – 6.1

​

Expected dividend yield

​

 

—

 

​

—

​

Fair value of Common Stock

​

$

1.40 – 7.98

 

$

3.34

​